Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Care Publish Ahead of Print published online ahead of print July 10, 2007
DOI: 10.2337/dc07-0348

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-0348v1
30/10/2695    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dehghan, A.
Right arrow Articles by Witteman, J. C.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dehghan, A.
Right arrow Articles by Witteman, J. C.M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Risk of type 2 diabetes mellitus attributable to C-reactive protein and other risk factors

Abbas Dehghan, MD, DSc1, Mandy van Hoek, MD2, Eric J.G. Sijbrands, MD, PhD2, Theo Stijnen, PhD1, Albert Hofman, MD, PhD1 and Jacqueline C.M. Witteman, PhD1

1 Department of Epidemiology & Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands
2 Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands

j.witteman{at}erasmusmc.nl

ABSTRACT

Objective -: To calculate the population attributable risk (PAR) of C-reactive protein (CRP) and other risk factors for type 2 diabetes.

Research design and methods -: The Rotterdam Study is a population-based, prospective follow-up study among 7983 participants aged 55 years and older. Risk factors including serum CRP were determined at baseline. Participants with diabetes at baseline were excluded and the cohort was followed for a mean of 10.8 years. The hazard ratio (HR) and the PAR for diabetes were computed for all studied risk factors.

Results -: Serum CRP >1mg/l (HR=1.67, PAR=0.33), body mass index >25 kg/m2 (HR=2.51, PAR=0.51), waist circumference > 102 for men and >88 for women (HR=1.36, PAR=0.14), current smoking (HR=1.16, PAR=0.03), age >65 years (HR=1.35, PAR=0.15), and family history of diabetes (HR=1.87, PAR=0.16), were related to diabetes and contributed to the risk of the disease. Serum CRP was a greater contributor to the risk of diabetes in women than in men (PAR values of 0.37 versus. 0.28, respectively). Age, and current smoking PARs were not statistically significantly contributing to the risk of diabetes in women. Combined PAR was 0.80 (95% CI: 0.74, 0.85) for all six studied risk factors and 0.71 (95% CI: 0.64, 0.78) for modifiable risk factors (serum CRP, BMI, waist circumference, and current smoking).

Conclusion -: High CRP is one of the major contributors to the risk of type 2 diabetes. The contribution of modifiable risk factors to the risk of diabetes is considerable.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
L. N. Pani, D. M. Nathan, and R. W. Grant
Clinical Predictors of Disease Progression and Medication Initiation in Untreated Patients With Type 2 Diabetes and A1C Less Than 7%
Diabetes Care, March 1, 2008; 31(3): 386 - 390.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.